CECOG Academy

www.cecog.org

 

Expert Discussion on Resectable/Borderline-Resectable PAC: Gemcitabine in Neoadjuvant Setting, Paclitaxel-Gemcitabine, Adjuvant QT + RT in R1 Resected Tumors

101 views
March 31, 2021
Comments 0
Login to view comments. Click here to Login